DOCSLIB.ORG

Management Stakeholders

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Management Stakeholders Hyperglycaemia in acute coronary syndromes: management Stakeholders 15 Healthcare 2gether NHS Foundation Trust 3M Health Care UK 4Children 5 Boroughs Partnership NHS Foundation Trust A.Menarini Pharma U.K. S.R.L. Abbott Diabetes Care Abbott Diagnostics Division Abbott Diagnostics Division Abbott Laboratories Abbott Vascular Devices Abbott Vascular Devices AbbVie AbbVie Abertawe Bro Morgannwg University NHS Trust Achieving for Children Action Heart Action on Addiction Action on Hearing Loss Action on Smoking & Health Action on Smoking and Health Addaction Addenbrookes Hospital Addiction Today ADFAM Adults Strategy and Commissioning Unit Advisory Committee for Community Dentistry Advisory Council on the Misuse of Drugs Afiya Trust African Health Policy Network Aintree University Hospital NHS Foundation Trust Alcohol and Drug service Alcohol Focus Scotland Alcohol Use Disorders: Clinical Management Guideline Development Group Alcoholics Anonymous Alder Hey Children's NHS Foundation Trust Alere Alere Alere International Alere Ltd Alere Ltd Alkermes Inc All Party Parliamentary Group on Vascular Disease Allergan Ltd UK Alliance Boots plc Allocate Software PLC Alpha Medical American Medical Systems Inc. American Medical Systems Inc. American Medical Systems UK Ltd AMORE health Ltd AMORE health Ltd AMORE Studies Group AMORE Studies Group Aneurin Bevan University Health Board anglia community leisure Anglia University Anglian Community Enterprise Ark Therapeutics Ltd Arrhythmia Alliance Arrowe Park Hospital Assocation of NHS Occupational Physicians Association for Clinical Biochemistry and Laboratory Medicine Association for Cognitive Analytic Therapy Association for Continence Advice Association for Family Therapy and Systemic Practice in the UK Association for Improvements in the Maternity Services Association for Psychoanalytic Psychotherapy in the NHS Association for the Study of Obesity Association of Ambulance Chief Executives Association of Ambulance Chief Executives Association of Anaesthetists of Great Britain and Ireland Association of Anaesthetists of Great Britain and Ireland Association of Breastfeeding Mothers Association of British Clinical Diabetologists Association of British Dispensing Association of British Healthcare Industries Association of British Insurers Association of Children’s Diabetes Clinicians Association of Clinical Pathologists Association of Convenience Stores Association of Higher Education Programmes on Substance Misuse Association of Optometrists Association of Paediatric Anaesthetists of Great Britain and Ireland Association of Paediatric Emergency Medicine Association of Renal Industries Association of the British Pharmaceutical Industry Associazione Infermieristica per lo Studio delle Lesioni Cutanee Astrazeneca UK Ltd Astrazeneca UK Ltd Atkins Nutritional Inc Atrial Fibrillation Association Autistic Rights Movement UK, The Autonomed Ltd Avon, Gloucestershire and Wiltshire Strategic Health Authority B. Braun Medical Ltd Bailey Instruments Ltd BALANCE North East BALANCE North East Bard Limited Bard Limited Barnet Enfield and Haringey Mental Health Trust Barnsley Hospital NHS Foundation Trust Barnsley Hospital NHS Foundation Trust Basildon and Thurrock University Hospitals NHS Foundation Trust Baxter Healthcare LTD Bayer HealthCare Bayer plc BD Medical - see Becton Dickenson BD U.K. Ltd Beckman Coulter Becton Dickinson Belfast Health and Social Care Trust Belfast Health and Social Care Trust Berkshire Local Pharmaceutical Committees Betsi cadwaladr Betsi Cadwaladr University Health Board BGP Products Birmingham and Solihull Mental Health NHS Foundation Trust Birmingham and Solihull NHS Cluster Birmingham City Council Birmingham Women’s NHS Foundation Trust Birmingham Women's Health Care NHS Trust Birmingham, Sandwell and Solihull Cardiac and Stroke Network Black And Ethnic Minority Diabetes Association Black and Ethnic Minority Diabetes Association Black Country Cancer and Cardiac Network Black Country Partnership Foundation Trust blackpool teaching hospitals nhs trust Blackpool, Fylde and Wyre Hospitals NHS Foundation Trust Blood Pressure UK Boehringer Ingelheim Boehringer Ingelheim Boehringer Ingelheim Ltd Bolton Council Bolton Council Bolton Hospitals NHS Trust Boots Boston Scientific Bournemouth Diabetes and Endocrine Centre Bradford District Care Trust Bradford Teaching Hospitals NHS Foundation Trust Brahms UK Limited-Thermo Fisher Scientific Brahms UK Limited-Thermo Fisher Scientific Breakspear Medical Group Ltd Brighton and Sussex University Hospital NHS Trust Brighton and Sussex University Hospital NHS Trust Bristol-Myers Squibb Pharmaceuticals Ltd British Acupuncture Council British Acupuncture Council British and Irish Orthoptic Society British Association for Applied Nutrition and Nutritional Therapy British Association for Counselling and Psychotherapy British Association for Counselling and Psychotherapy British Association for Nursing in Cardiovascular Care British Association for Parenteral & Enteral Nutrition British Association for Psychopharmacology British Association for Sexual Health and HIV British Association of Art Therapists British Association of Behavioural and Cognitive Psychotherapies British Association of Cardiac Rehabilitation British Association of Dramatherapists British Association of Prosthetists & Orthotists British Association of Psychodrama and Sociodrama British Association of Social Workers British Association of Stroke Physicians British Cardiac Patients Association British Cardiovascular Intervention Society British Cardiovascular Society British Cardiovascular Society British Dental Association British Dietetic Association British Dietetic Association British Geriatrics Society British Geriatrics Society British Geriatrics Society-Special Interest Group in Diabetes British Healthcare Trades Association British Heart Foundation British Heart Foundation British Hyperbaric Association British Hypertension Society British Infection Association British Institute of Musculoskeletal Medicine British Liver Trust British Medical Association British Medical Association British Medical Journal British Medical Journal British National Formulary British National Formulary British Nuclear Cardiology Society British Nuclear Cardiology Society British Nuclear Medicine Society British Nuclear Medicine Society British Nutrition Foundation British Obesity Surgery Society British Orthopaedic Foot & Ankle Society British Paediatric Mental Health Group British Pain Society British Pain Society British Paramedic Association British Paramedic Association British Pharmacological Society British Pharmacological Society British Psychodrama Association British Psychological Society British Psychological Society British Red Cross British Red Cross British Renal Society British Society for Antimicrobial Chemotherapy British Society for Disability and Oral Health British Society for Human Genetics British Society for Human Genetics British Society for Immunology British Society for Paediatric Endocrinology and Diabetes British Society for Sexual Medicine British Society of Cardiovascular Imaging British Society of Cardiovascular Magnetic Resonance British Society of Dental Hygiene & Therapy British Society of Echocardiography British Society of Gastroenterology British Society of Interventional Radiology British Society of Paediatric Gastroenterology Hepatology and Nutrition British Society of Periodontology British Society of Rehabilitation Medicine BSN Medical Buckinghamshire Hospitals NHS Trust BUPA Foundation C. R. Bard, Inc. Calderdale and Huddersfield NHS Trust Calderstones Partnerships NHS Foundation Trust Cambridge University Hospitals NHS Foundation Trust Cambridge University Hospitals NHS Foundation Trust Camden Link Camden Provider Services Cancer Research UK Caplond Services Capsulation PPS Capsulation PPS Cardiff and Vale NHS Trust Cardiff and Vale NHS Trust Cardiff University Care England Care Quality Commission Care Quality Commission Carers Together Carers Trust Castle street medical centre Cegedimrx Central & North West London NHS Foundation Trust Central Essex Community Services Central London Community Health Care NHS Trust Central Manchester University Hospitals Central Manchester University Hospitals NHS Foundation Trust Centre for Mental Health Research Chadderton Health Centre Chalice Medical Ltd Chartered Society of Physiotherapy Chartered Society of Physiotherapy Cheshire and Merseyside Cardiac Network Cheshire Diabetes Network Chester-le-Street Community Hospital CHiNWAG CHKS Ltd Chronic Disease Management Ltd CIS' ters City Healthcare Partnership CLEAR Cannabis Law Reform Cleft Lip and Palate Association Clinical Council for Eye Health Commissioning Coast to Coast Cardiac Network Cochrane Wounds Group Coeliac UK Collaboration for Leadership in Applied Health Research and Care College of Mental Health Pharmacy College of Occupational Therapists College of Optometrists College of Paramedics Coloplast Limited Community Diabetes Consultants Community District Nurses Association Community Practitioners' & Health Visitors Association ConvaTec Ltd Cook Medical Inc. Cook Medical Inc. Cordis Corporation counselling for prisoners network Counterweight Ltd Countess of Chester Hospital NHS Foundation Trust County Durham and Darlington Acute Hospitals NHS Trust County Durham and Darlington Diabetes Clinical Advisory Group County Durham and Darlington NHS Foundation Trust Coventry and Warwickshire Cardiac Network Coventry and Warwickshire Cardiac Network Coverage
Load more

Recommended publications
  • Corporate Social Responsibility Report 2016 Walgreens Boots Alliance Is the First Global Pharmacy-Led, Health and Wellbeing Enterprise
    Corporate Social Responsibility Report 2016 Walgreens Boots Alliance is the first global pharmacy-led, health and wellbeing enterprise. Our purpose is to help people across the world lead healthier and happier lives. Our 2016 Corporate Social Responsibility Report covers the fiscal year that ended 31 August 2016. In this year’s report: Overview Marketplace Introduction ...................................................1 Our CSR goals .............................................2 28 Our vision, purpose and values ................3 Our approach to CSR .................................4 Contributing to the United Nations Sustainable Development Goals .............6 Transparency ........................................... 30 Our impact ...................................................8 Ethical Sourcing ...................................... 30 ........................... About our Company ................................. 10 External Stakeholders 31 Stakeholder engagement ....................... 12 Workplace Community 32 14 Employee Health and Wellbeing ........ 34 Equal Opportunities .............................. 36 Health and Wellbeing ............................. 16 Health and Safety ...................................37 Young People ........................................... 17 ...................................... Cancer Programs .....................................20 About this report 38 Data management process ................ 38 Environment Data ............................................................ 38 Community data
    [Show full text]
  • OSB Participant List by Research Area
    OSB Participant List by Research Area Contact Centers (CC) • AARP • Air Products and • American Drug Stores Chemicals • AAA • ABB • American Electric Power • Airbus • Accor • Abbott • American Express • Alcatel Lucent • American Electric Power • Abengoa • American International • Alcoa Group • American International • Abu Dhabi National Group Energy Company • Alcon • American Stores Company • Austin Energy • ACC Limited • Alfa • American Water • Bank of America • Access Insurance Holdings • Algonquin Power & • Amgen Utilities • Blue Cross Blue Shield • Accord Holdings • AMIL • ALH Group • Charles Schwab & • ACE • AmInvestment Bank Company • Alitalia • Acea • AMR • Citigroup • ALK Abello • Acer • Amssi • Citizens Gas • Alkermes • Acxiom • Amtran Logistics • Clarke American • Allergan • Adelaide Clinic Holdings • Andrew Corporation • CPS Energy • Alliance & Leicester • Adidas • Anglian Water Services • Direct Energy • Alliance Boots • Advance Food Company • Anritsu • Federal Reserve Bank of • Alliant Techsystems Minneapolis • Advance Publications • Anschutz • Allianz • John Deere • Advanced Coating • Apache • Allied Irish Banks • Technologies Louisville Water Company • Apex Equity Holdings • Advanced Semiconductor • Allstate Insurance • Manila Electric Company Engineering Company • Apple • • • Mellon Financial Adventist Health System Ally Financial • Arcadia Housing • • • MetLife Aegon Alon USA Energy • Arcos Dorados Holdings • • • Morgan Stanley AEON AlpTransit Gotthard • Ardent Health Services • • • NetBank Aera Energy Alstom • Argos •
    [Show full text]
  • Local Businesses – Large and Small
    Local Businesses – Large and Small The details of the local businesses documented below have been researched by the Local History Group. Thomas Glover & Son Thomas Glover & Son, elastic web and fabric manufacturers appeared in the Post Office Directory for Nottinghamshire in 1855. The company is recorded as having several addresses in Nottingham, however it had disappeared from the directory by 1900, returning in 1925 described as a surgical hosier in Chesterfield Street, Carlton. The firm remained at that address until the 1970s. The company’s buildings were on both sides of Chesterfield Street but are now demolished, new houses being built on the side. Turney Brothers In 1861 two brothers, Edward and John Turney built a tannery and began to make leather on a site next to the River Trent and the adjacent canal in Nottingham, known as Sneinton Island. The first buildings took up only a fraction of the space that by the 1920s had developed into a large site with labour-saving machinery imported from many countries. They traded under the name of Turney Brothers and had offices in London, Leicester and Manchester. Edward left some years after the commencement of the company and the driving force was John Turney who was in sole charge for over a quarter of a century. In 1888 the company re-organised into a Limited Company, John being chairman. John led an exceptionally distinguished social, political and commercial life. He was a member of Nottingham Corporation for 46 years, and became Sheriff and then Alderman in 1879 and Mayor for two years 1886 – 1888.
    [Show full text]
  • Leicester, Leicestershire and Rutland (LLR) Local Digital Roadmap 2016 - 2021 Contents
    Leicester, Leicestershire and Rutland (LLR) Local Digital Roadmap 2016 - 2021 Contents Foreword for Local Digital Roadmap 2 5. Capabilities 38 5.1 Paper free at Point of Care groups 1. Introduction 4 of capabilities 38 1.1 Our Journey in Delivering the 5.1.1 Records, assessments and plans 38 Five Year Forward View and Personalised 5.1.2 Transfers of care 41 Health and Care 2020 4 5.1.3 Orders and results management 43 1.2 Overview of Organisations Covered 6 5.1.4 Medicines management and optimisation 43 1.3 Sustainability and Transformation Plan 5.1.5 Decision support 45 (STP) Alignment 6 5.1.6 Remote care 46 1.3.1 Better Care Together (BCT) 7 5.1.7 Asset and resource optimisation 49 1.4 Leicester, Leicestershire and Rutland (LLR) 5.2 16/17-17/18 Universal capabilities 54 Context 8 5.3 Capabilities Delivery Plan 55 2. A vision for digitally-enabled 6. Information Sharing 56 transformation 19 6.1 Information Sharing Strategy 56 6.2 Information Governance 56 6.3 Interoperability Strategy 57 3. Baseline Position 20 3.1 Current Technology Landscape 20 7. Infrastructure 58 3.1.1 Data Sharing 20 3.1.2 Patient Access 21 3.1.3 Electronic Prescriptions 21 8. Minimising risks arising from 3.1.4 Electronic Clinical Correspondence 21 technology 63 3.1.5 Business Intelligence 21 3.1.6 System Access 22 9. Timescales and Delivery of the 3.1.7 Pathways 22 Local Digital Roadmap 64 3.1.8 Patient Focused Apps 22 2016/17 64 3.2 Rate limiting factors 23 2017/18 66 2018/19 68 4.
    [Show full text]
  • Corporate Finance Guide 2021 CORPORATE FINANCE GUIDE SPECIAL | CORPORATE
    01/06/2021 15:30 15:30 01/06/2021 01/06/2021 1 1 cover.indd cover.indd Guide Guide Finance Finance Corporate Corporate MIDLANDS BUSINESS INSIDER www.midlandsbusinessinsider.com JULY 2021 JULY midlands businessinsider WEST ™ MIDLANDS insiderEDITION VOL.29 NO.7 £10 JULY 2021 West Midlands Mayor What does business want from Andy Street’s second term? CITY OF CULTURE CITY OFCULTURE Wolverhampton The new home of green construction | SMEGUIDE Mental health | MENTAL HEALTH HEALTH MENTAL Helping a colleague on the edge | RESIDENTIAL AWARDS RESIDENTIALAWARDS | CORPORATE FINANCEGUIDESPECIAL CORPORATE Guide Guide 2021 Corporate Finance Corporate MIDLANDS | CIRCULARECONOMY FIREDHOW A YEAR AS CITY OF CULTURE UP! IS VOL.29 N VOL.29 SPARKING GROWTH IN COVENTRY O 7 MBI July 2021 cover MASTER.indd 1 02/06/2021 15:00 Optimising outcomes for our clients no matter what their destination DLA Piper has been the No 1 M&A law firm, both in the UK and globally, for each of the past 11 years. Trusted adviser to: Put simply, we do things that other law firms cannot. Times 2 SISTERS FOOD GROUP may change, but our qualities do not. Our clients trust us with Advised on the GBP246m sale of part of Fox’s Biscuits to their most important, strategic and transformational M&A and Ferrero Group. ECM transactions. We use our market and sector intelligence and unrivalled deal execution experience to drive and obtain NOBLE GROUP optimal outcomes for our clients, no matter what the deal type, Advised on the sale of chilled dessert brand Gü to Exponent the transaction process, the geography or the counter-party.
    [Show full text]
  • Download Annual Report 2013
    Annual Report 2013 Our goal Our goal is to become Central and Eastern Europe’s leading spirits company – commanding a major stake in each of our core operating markets and making our presence felt in the wider global market. Contents Strategic report Chairman’s statement 02 Group at a glance 04 Our “millionaire” brands 06 Our heritage 08 Chief Executive Officer’s statement 10 Our business model 14 Strategy and KPIs 16 Our markets 18 HIGHLIGHTS Spirits market overview 20 Regional reviews Poland 22 17.4 m €340.5m Czech Republic 24 Italy 26 9 LITRE CASES NET SALES REVENUE Other 27 +11.4% +16.4% Operations 28 2012: 15.6m 9 litre cases 2012: €292.4m Our people 29 Corporate responsibility 30 €83.7m €47.7m Financial review 32 Principal risks 36 ADJUSTED EBITDA* OPERATING PROFIT Directors and +22.3% -44.2% Company Secretary 42 2012: €68.4m 2012: €85.4m Senior management 44 Corporate governance 46 Chairman’s letter 46 €74.4 m €8.9m Corporate governance framework 47 ADJUSTED EBIT* PROFIT FOR THE YEAR Audit Committee report 52 +26.7% -66.0% 2012: €58.7m 2012: €26.2m Nomination Committee report 56 Directors’ remuneration * Stock Spirits Group uses alternative performance measures as key financial indicators to assess the underlying performance of the Group. These include adjusted EBITDA, adjusted EBIT and adjusted free cash flow. report 57 The narrative in the Annual Report & Accounts is based on these alternative measures and an explanation is set out in note 7 to the consolidated financial statements included in the Annual Report & Accounts.
    [Show full text]
  • Board of Directors
    Board of Directors Time: 1310-1430 hours Venue Date: Wednesday, 31 October 2018 Room 3, 3rd Floor, Unit 2 (Battersea Studio 2), Battersea, London SW8 3HR1 Presenters are reminded to provide a succinct and focused introduction, highlighting the key questions and only things which have changed since the preparation of the report 1 Administrative and other priority items 1.1 Welcome, introduction and apologies: Angela Greatley Verbal 1310 2 1.2 Patient story Hilder Dewa Verbal 1.3 Written questions from the public3 Angela Greatley Verbal 1.4 Interests relevant to the agenda to declare and any new Angela Greatley Verbal interests 1.5 Minutes of meeting held on 20.09.18 and Angela Greatley Pages 3 - 4 27.09.18 Pages 5 - 9 1.6 Matters arising and action log Angela Greatley Page 10 1.7 Chair’s report Angela Greatley Pages 11 - 13 1.8 Chief Executive’s report Andrew Ridley Pages 14 - 23 1.9 Quality report – Q2 Charlie Sheldon Pages 24 - 79 2 Strategic items 2.1 Operational plan 2019/20 – timescales and planned Mike Fox Pages 80 - 91 1335 approval process / dates 2.2 Clinical strategy – refresh – aligned to organisational Joanne Medhurst Pages 92 - 105 strategy – agreed in March 2017 3 Operational items 3.1 Integrated finance and performance report M6 Mike Fox Pages 106 - 127 1350 Jitesh Chotai To be provided 3.1.1 FRIC report, 29.10.18 separately 4 3.2 Learning from deaths – Q2 report Joanne Medhurst Pages 128 - 131 3.3 Health and safety policy - Q2 report Elizabeth Hale Pages 132 - 151 3.4 STP / Partnerships update – Q2 report James Benson Pages
    [Show full text]
  • Glaxosmithkline Aims to Divest Many OTC Brands
    OTC11-02-11p1&28FIN.qxd 8/2/11 11:52 Page 1 11 February 2011 COMPANY NEWS 3 GlaxoSmithKline aims to Valeant expands in CEE 3 with PharmaSwiss deal J&J loses sales of US$1.1bn 4 Boots faces up to tough market 5 divest many OTC brands Key brands boost Novartis OTC sales 6 GSK consumer races ahead 7 laxoSmithKline intends to divest non- to divest the non-core brands as soon as pos- Taisho holds steady in weak market 8 Gcore OTC brands with combined an- sible – hopefully before the end of the year – Vicks shipments lift OTC at P&G 9 nual sales of £500 million (C593 million). depending on buyer interest. Perrigo plans spring Allegra launch 10 Chief executive officer Andrew Witty said The announcement came as GlaxoSmith- Consumer Care grows at Merck & Co 11 the move would enable the company’s Con- Kline reported a 7% rise – 5% at constant ex- Omega reports strong quarter 12 sumer Healthcare division to focus more effec- change rates – in 2010 sales at the Consumer Winter woes hit Boiron 13 tively on its “priority or global” brands as well Healthcare division to £5.01 billion. Sales in Pfizer wants Consumer 14 as its operations in emerging markets. Consumer Healthcare’s OTC Medicines busi- to prove worth A spokesperson for GlaxoSmithKline told ness grew by 5% – 3% at constant exchange OTC bulletin that the company was currently rates – to £2.46 billion. GENERAL NEWS 15 compiling the lists of priority and non-core OTC brands, and hoped to release more details Recent deals with Meda and Valeant Perrigo faces lawsuit over 15 in the second quarter of the year.
    [Show full text]
  • The World's Leading AI in Medicine Summit
    The world’s leading AI in medicine summit Wednesday 5th February 2020 London, UK http://www.intelligenthealth.ai/ The mission? Intelligent Health, in partnership with NHSX, will bring the global AI and health community to London in February 2020 for a one-day event to advance discussions on how to apply AI and drive technological collaboration in healthcare. 800+ delegates will join industry leading global speakers for an in-depth look at AI within the UK health market, how it can be used to prevent and solve some of the world’s greatest healthcare problems, improve the health of the human race and set the UK AI agenda in healthcare for 2020 and beyond. What’s on? Jam-packed day of health tech goodness! Practical, real-world AI use cases, announcements from tech giants, hear from health tech transformers of tomorrow and a showcase of innovation, followed by 10 collaborative hands-on sessions tackling live digital health challenges. Be ready to think like a physician and code like a developer. Wednesday 5th February 2020 07:30 REGISTRATION Session One 09:00 – 11:00 09:00 WELCOME Inspired Minds Denise Tack, Strategy Director - Health, Inspired Minds WELCOME NHSX Tara Donnelly, CDIO, NHSX WELCOME and chairperson’s opening remarks Sameena Ali-Khan, Television Presenter, ITV 09:20 HEADLINER Leading digital change, interoperability and innovation – how the NHS will work more effectively with larger tech firms and digital health innovators Tara Donnelly, CDIO, NHSX 09:45 HEADLINER Maximising our digital infrastructure for a 21st century workforce Frank Hester, Founder and CEO, The Phoenix Partnership 10:10 HEADLINER Inside Pandora's Black Box: Understanding decision-making in diagnostic AI and its implications for clinician skills Dr.
    [Show full text]
  • Hydroxychloroquine for Prevention of COVID-19 Mortality: a Population-Based Cohort Study
    medRxiv preprint doi: https://doi.org/10.1101/2020.09.04.20187781; this version posted September 9, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license . Hydroxychloroquine for prevention of COVID-19 mortality: a population-based cohort study Christopher T Rentsch1*&, Nicholas J DeVito2*, Brian MacKenna2*, Caroline E Morton2*, Krishnan Bhaskaran1, Jeremy P Brown1, Anna Schultze1, William J Hulme2, Richard Croker2, Alex J Walker2, Elizabeth J Williamson1, Chris Bates3, Seb Bacon2, Amir Mehrkar2, Helen J Curtis2, David Evans2, Kevin Wing1, Peter Inglesby2, Rohini Mathur1, Henry Drysdale2, Angel YS Wong1, Helen I McDonald1, Jonathan Cockburn3, Harriet Forbes1, John Parry3, Frank Hester3, Sam Harper3, Liam Smeeth1, Ian J Douglas1, William G Dixon4, Stephen JW Evans1, Laurie Tomlinson1†, Ben Goldacre2† 1 Electronic Health Records Research Group, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London WC1E 7HT 2 The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Woodstock Rd, Oxford OX2 6GG 3 The Phoenix Partnership, 129 Low Lane, Horsforth, Leeds LS18 5PX 4 Centre for Epidemiology Versus Arthritis, The University of Manchester, Oxford Road, Manchester M13 9PL *These authors contributed equally to this work †Joint principal investigators &corresponding: [email protected]; @DarthCTR NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. 1 medRxiv preprint doi: https://doi.org/10.1101/2020.09.04.20187781; this version posted September 9, 2020.
    [Show full text]
  • WALGREENS BOOTS ALLIANCE, INC . (Exact Name of Registrant As Specified in Its Charter) Delaware 47-1758322 (State of Incorporation) (I.R.S
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended August 31, 2016 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From ____________ to ___________ Commission file number 001-36759 WALGREENS BOOTS ALLIANCE, INC . (Exact name of registrant as specified in its charter) Delaware 47-1758322 (State of incorporation) (I.R.S. Employer Identification No.) 108 Wilmot Road, Deerfield, Illinois 60015 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: (847) 315-2500 Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of each exchange on which registered Common Stock ($.01 Par Value) The NASDAQ Stock Market LLC 2.875% Notes due 2020 New York Stock Exchange 3.600% Notes due 2025 New York Stock Exchange 2.125% Notes due 2026 New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.
    [Show full text]
  • The Inversion Experience in the United States
    The Inversion Experience in the United States ITPF/TPC Conference on Corporate Inversions and Tax Policy Paul W. Oosterhuis Skadden, Arps, Slate, Meagher & Flom Washington, D.C. January 23, 2015 Beijing Houston Palo Alto Tokyo Boston London Paris Toronto Brussels Los Angeles São Paulo Washington, D.C. Chicago Moscow Shanghai Wilmington Frankfurt Munich Singapore Hong Kong New York Sydney │1 Skadden, Arps, Slate, Meagher & Flom LLP EVOLUTION OF INVERSION TRANSACTIONS Edit│2 on Slide Master │2 Skadden, Arps, Slate, Meagher & Flom LLP INTRODUCTION • This presentation provides background regarding various “inversion” related transactions, and the evolution of those transactions in response to the changing legal landscape. • The basic concept of an inversion is a transaction in which a U.S. parent becomes a subsidiary of a new foreign parent corporation (“NFP”). − If done alone under NFP this is a “self inversion” (Aon, Ensco, etc.). − If done in connection with a target (typically foreign) under NFP this is a combination migration transaction (Eaton/Cooper, Medtronic/Covidien, etc.). • Inversions offer fours main areas of potential tax benefits: 1) Future foreign expansion under NFP outside of the U.S. tax “net” 2) Tax efficient leverage on the group’s U.S. operations 3) Restructuring of legacy foreign operations owned by the U.S. group 4) Better access to offshore cash for NFP dividends, share buybacks, etc. │3 Skadden, Arps, Slate, Meagher & Flom LLP THE START: MCDEROMOTT TRANSACTION (1980’s) Public Public Public McDermott McDermott McDermott
    [Show full text]